{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:12:26Z","timestamp":1755216746805,"version":"3.43.0"},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T00:00:00Z","timestamp":1618963200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/ http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:p>Refractory stage M neuroblastoma (NB) is associated with a poor prognosis and a progressive course of disease. Here, we describe a unique group of patients with a discrepant clinical course. Seven histologically confirmed ganglioneuroblastoma (GNB) (n=6) and differentiating NB (n=1) patients were identified who were diagnosed with stage M disease based on iodine-123-metaiodobenzylguanidine avid bone metastases. Six patients started on high-risk treatment, without tumor response (stable disease). Treatment was discontinued before the start of consolidation treatment because of refractory response in all patients. Unexpectedly, after cessation of treatment no progression of disease occurred. In 2 patients, the primary tumors expanded (&gt;25%) very slowly during 1.5 and 3 years, and remained stable thereafter. Metabolically, a slow decrease of urinary homovanillic acid and vanillylmandelic acid levels and iodine-123-metaiodobenzylguanidine avidity was observed. All patients are alive with presence of metastatic disease after a median follow-up of 17 years (range: 6.7 to 27\u2009y). Interestingly, at diagnosis, 6 patients were asymptomatic, 6 patients had GNB morphology, and 5 patients had meningeal metastases. These are all features seen in only a small minority of stage M patients. This GNB entity illustrates the clinical heterogeneity of neuroblastic tumors and can be used to further study the developmental origin of different NB subtypes.<\/jats:p>","DOI":"10.1097\/mph.0000000000002067","type":"journal-article","created":{"date-parts":[[2021,4,22]],"date-time":"2021-04-22T22:42:44Z","timestamp":1619131364000},"page":"e5-e13","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Refractory Stage M Ganglioneuroblastoma With Bone Metastases and a Favorable, Chronic Course of Disease: Description of a Patient Cohort"],"prefix":"10.1097","volume":"44","author":[{"given":"Michelle L.","family":"Tas","sequence":"first","affiliation":[{"name":"Solid Tumors"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan J.","family":"Molenaar","sequence":"additional","affiliation":[{"name":"Solid Tumors"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annemarie M.L.","family":"Peek","sequence":"additional","affiliation":[{"name":"Solid Tumors"},{"name":"Department of Pediatric Oncology, Beatrix Children\u2019s Hospital, University Medical Center Groningen, Groningen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maarten H.","family":"Lequin","sequence":"additional","affiliation":[{"name":"Solid Tumors"},{"name":"Radiology and Nuclear Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rob M.","family":"Verdijk","sequence":"additional","affiliation":[{"name":"Department of Pathology, Section Neuropathology, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald R.","family":"de Krijger","sequence":"additional","affiliation":[{"name":"Diagnostics and Pathology, Princess M\u00e1xima Center for Pediatric Oncology"},{"name":"Pathology, University Medical Center Utrecht, Utrecht"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Godelieve A.M.","family":"Tytgat","sequence":"additional","affiliation":[{"name":"Solid Tumors"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Max M.","family":"van Noesel","sequence":"additional","affiliation":[{"name":"Solid Tumors"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,4,21]]},"reference":[{"key":"R1-20250804","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1200\/JCO.2008.16.6785","article-title":"The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report","volume":"27","author":"Cohn","year":"2009","journal-title":"J Clin Oncol"},{"key":"R2-20250804","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1200\/JCO.2014.59.4648","article-title":"Advances in risk classification and treatment strategies for neuroblastoma","volume":"33","author":"Pinto","year":"2015","journal-title":"J Clin Oncol"},{"key":"R3-20250804","doi-asserted-by":"crossref","first-page":"e28061","DOI":"10.1002\/pbc.28061","article-title":"Neuroblastoma stage 4S: tumor regression rate and risk factors of progressive disease","volume":"67","author":"Tas","year":"2020","journal-title":"Pediatr Blood Cancer"},{"key":"R4-20250804","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1471-2407-11-21","article-title":"Long term outcome of high-risk neuroblastoma patients after immunotherapy with antibody ch14.18 or oral metronomic chemotherapy","volume":"11","author":"Simon","year":"2011","journal-title":"BMC Cancer"},{"key":"R5-20250804","doi-asserted-by":"crossref","first-page":"e150","DOI":"10.1097\/MPH.0000000000000308","article-title":"Additional therapies to improve metastatic response to induction therapy in children with high-risk neuroblastoma","volume":"37","author":"Schrey","year":"2015","journal-title":"J Pediatr Hematol Oncol"},{"key":"R6-20250804","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0009-8981(84)90181-5","article-title":"Simultaneous determination of catecholamines and metanephrines in urine by HPLC with fluorometric detection","volume":"137","author":"Abeling","year":"1984","journal-title":"Clin Chim Acta"},{"key":"R7-20250804","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1200\/JCO.2016.72.0177","article-title":"Revisions to the International Neuroblastoma Response Criteria: a Consensus Statement From the National Cancer Institute Clinical Trials Planning Meeting","volume":"35","author":"Park","year":"2017","journal-title":"J Clin Oncol"},{"key":"R8-20250804","doi-asserted-by":"crossref","first-page":"4959","DOI":"10.1158\/1078-0432.CCR-11-0462","article-title":"To DNA or not to DNA? That is the question, when it comes to molecular subtyping for the clinic!","volume":"17","author":"Smeets","year":"2011","journal-title":"Clin Cancer Res"},{"key":"R9-20250804","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/ng.3333","article-title":"Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations","volume":"47","author":"Eleveld","year":"2015","journal-title":"Nat Genet"},{"key":"R10-20250804","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ejca.2019.09.025","article-title":"Neuroblastoma between 1990 and 2014 in the Netherlands: increased incidence and improved survival of high-risk neuroblastoma","volume":"124","author":"Tas","year":"2020","journal-title":"Eur J Cancer"},{"key":"R11-20250804","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.ejca.2008.01.010","article-title":"Iodine-131-metaiodobenzylguanidine as initial induction therapy in stage 4 neuroblastoma patients over 1 year of age","volume":"44","author":"de Kraker","year":"2008","journal-title":"Eur J Cancer"},{"key":"R12-20250804","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S1470-2045(08)70069-X","article-title":"High-dose rapid and standard induction chemotherapy for patients aged over 1 year with stage 4 neuroblastoma: a randomised trial","volume":"9","author":"Pearson","year":"2008","journal-title":"Lancet Oncol"},{"key":"R13-20250804","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1200\/JCO.1987.5.12.1952","article-title":"Sequential cisplatin\/VM-26 and vincristine\/cyclophosphamide\/doxorubicin in metastatic neuroblastoma: an effective alternating non-cross-resistant regimen?","volume":"5","author":"Bernard","year":"1987","journal-title":"J Clin Oncol"},{"key":"R14-20250804","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/mpo.2950240307","article-title":"Cyclophosphamide\/doxorubicin vs. cisplatin\/teniposide in the treatment of children older than 12 months of age with disseminated neuroblastoma: a Pediatric Oncology Group Randomized Phase II study","volume":"24","author":"McWilliams","year":"1995","journal-title":"Med Pediatr Oncol"},{"key":"R15-20250804","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1002\/pbc.24207","article-title":"Feasibility of a tandem autologous peripheral blood stem cell transplant regimen for high risk neuroblastoma in a cooperative group setting: a Pediatric Oncology Group study: a report from the Children\u2019s Oncology Group","volume":"59","author":"Granger","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"R16-20250804","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/00043426-199905000-00005","article-title":"Metastatic sites in stage IV and IVS neuroblastoma correlate with age, tumor biology, and survival","volume":"21","author":"DuBois","year":"1999","journal-title":"J Pediatr Hematol Oncol"},{"key":"R17-20250804","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1002\/1097-0142(20011101)92:9<2451::AID-CNCR1595>3.0.CO;2-S","article-title":"International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors: a report from the Children\u2019s Cancer Group","volume":"92","author":"Shimada","year":"2001","journal-title":"Cancer"},{"key":"R18-20250804","doi-asserted-by":"crossref","first-page":"37730","DOI":"10.18632\/oncotarget.17146","article-title":"Clinical and biological features of neuroblastic tumors: a comparison of neuroblastoma and ganglioneuroblastoma","volume":"8","author":"He","year":"2017","journal-title":"Oncotarget"},{"key":"R19-20250804","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1186\/s12885-016-2513-9","article-title":"Treatment and outcome of ganglioneuroma and ganglioneuroblastoma intermixed","volume":"16","author":"Decarolis","year":"2016","journal-title":"BMC Cancer"},{"key":"R20-20250804","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1200\/JCO.2006.08.8799","article-title":"Retrospective study of childhood ganglioneuroma","volume":"26","author":"De Bernardi","year":"2008","journal-title":"J Clin Oncol"},{"key":"R21-20250804","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1002\/1097-0142(20010515)91:10<1905::AID-CNCR1213>3.0.CO;2-4","article-title":"Metabolic activity and clinical features of primary ganglioneuromas","volume":"91","author":"Geoerger","year":"2001","journal-title":"Cancer"},{"key":"R22-20250804","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/pbc.22106","article-title":"Clinicopathological characteristics of ganglioneuroma and ganglioneuroblastoma: a report from the CCG and COG","volume":"53","author":"Okamatsu","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"R23-20250804","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/MPH.0b013e318221ca82","article-title":"Multiple persistent ganglioneuromas likely arising from the spontaneous maturation of metastatic neuroblastoma","volume":"34","author":"Rozmus","year":"2012","journal-title":"J Pediatr Hematol Oncol"},{"key":"R24-20250804","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1002\/1097-0142(19890315)63:6<1211::AID-CNCR2820630628>3.0.CO;2-1","article-title":"Clinical manifestations of ganglioneuroma","volume":"63","author":"Hayes","year":"1989","journal-title":"Cancer"},{"key":"R25-20250804","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/1097-0142(19840715)54:2<357::AID-CNCR2820540230>3.0.CO;2-4","article-title":"Ganglioneuroma presenting with differentiated skeletal metastases. Report of a case","volume":"54","author":"Garvin","year":"1984","journal-title":"Cancer"},{"key":"R26-20250804","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1699-0463.1963.tb01589.x","article-title":"Transformation of sympathicoblastoma into ganglioneuroma, with a case report","volume":"58","author":"Visfeldt","year":"1963","journal-title":"Acta Pathol Microbiol Scand"},{"key":"R27-20250804","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/S1079-2104(99)70090-9","article-title":"Metastatic neuroblastoma with ganglioneuromatous differentiation and mandibular involvement","volume":"88","author":"Bhattacharyya","year":"1999","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"R28-20250804","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0368-2242(55)80004-8","article-title":"Maturation of tumors of the sympathetic nervous system","volume":"7","author":"Kissane","year":"1955","journal-title":"J Fac Radiol"},{"key":"R29-20250804","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1002\/1097-0142(196511)18:11<1510::AID-CNCR2820181124>3.0.CO;2-H","article-title":"Maturation of tumors of the sympathetic nervous system. Report of long-term survival in 2 patients, one with disseminated osseous metastases, and review of cases from the literature","volume":"18","author":"Goldman","year":"1965","journal-title":"Cancer"},{"key":"R30-20250804","first-page":"518","article-title":"Metastatic ganglioneuroblastoma: report of case and review of the literature","volume":"32","author":"Mitcherling","year":"1974","journal-title":"J Oral Surg"},{"key":"R31-20250804","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ijom.2008.09.009","article-title":"Ganglioneuroma of the mandible resulting from metastasis of neuroblastoma","volume":"38","author":"Patterson","year":"2009","journal-title":"Int J Oral Maxillofac Surg"},{"key":"R32-20250804","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0030-4220(89)90193-X","article-title":"Ganglioneuroma of the mandible","volume":"68","author":"Chou","year":"1989","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"R33-20250804","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.2106\/00004623-199911000-00011","article-title":"Symptomatic ganglioneuroma of bone. A case report","volume":"81","author":"Mithofer","year":"1999","journal-title":"J Bone Joint Surg Am"},{"key":"R34-20250804","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1067\/moe.2000.103646","article-title":"Ganglioneuroma of the mandible: radiologic and pathologic findings of a rare tumor","volume":"89","author":"Oeppen","year":"2000","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"R35-20250804","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/0030-4220(91)90369-N","article-title":"Unusual intramandibular neural tumor","volume":"71","author":"Hustin","year":"1991","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"R36-20250804","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1084\/jem.20191871","article-title":"Ganglioneuromas are driven by activated AKT and can be therapeutically targeted with mTOR inhibitors","volume":"217","author":"Tao","year":"2020","journal-title":"J Exp Med"},{"key":"R37-20250804","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/cncr.11448","article-title":"Central nervous system metastases in neuroblastoma: radiologic, clinical, and biologic features in 23 patients","volume":"98","author":"Matthay","year":"2003","journal-title":"Cancer"},{"key":"R38-20250804","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1002\/1097-0142(20010415)91:8<1510::AID-CNCR1159>3.0.CO;2-I","article-title":"Neuroblastoma metastatic to the central nervous system. The Memorial Sloan-kettering Cancer Center experience and a literature review","volume":"91","author":"Kramer","year":"2001","journal-title":"Cancer"},{"key":"R39-20250804","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejca.2016.06.005","article-title":"Prognostic significance of pattern and burden of metastatic disease in patients with stage 4 neuroblastoma: a study from the International Neuroblastoma Risk Group database","volume":"65","author":"Morgenstern","year":"2016","journal-title":"Eur J Cancer"},{"key":"R40-20250804","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00234-010-0697-2","article-title":"Common and unusual craniofacial manifestations of metastatic neuroblastoma","volume":"52","author":"D\u2019Ambrosio","year":"2010","journal-title":"Neuroradiology"},{"key":"R41-20250804","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/0012-1606(87)90118-7","article-title":"Mapping of the early neural primordium in quail-chick chimeras. II. The prosencephalic neural plate and neural folds: implications for the genesis of cephalic human congenital abnormalities","volume":"120","author":"Couly","year":"1987","journal-title":"Dev Biol"},{"key":"R42-20250804","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1242\/dev.114.1.1","article-title":"The developmental fate of the cephalic mesoderm in quail-chick chimeras","volume":"114","author":"Couly","year":"1992","journal-title":"Development"},{"key":"R43-20250804","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1097\/00005072-198609000-00008","article-title":"The meninges in human development","volume":"45","author":"O\u2019Rahilly","year":"1986","journal-title":"J Neuropathol Exp Neurol"},{"key":"R44-20250804","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1126\/science.aal3753","article-title":"Multipotent peripheral glial cells generate neuroendocrine cells of the adrenal medulla","volume":"357","author":"Furlan","year":"2017","journal-title":"Science"},{"key":"R45-20250804","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/dgd.12189","article-title":"Sympathoadrenal neural crest cells: the known, unknown and forgotten?","volume":"57","author":"Lumb","year":"2015","journal-title":"Dev Growth Differ"},{"key":"R46-20250804","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S1470-2045(12)70012-8","article-title":"Neuroblastoma stage 4S: a multifocal stem-cell disease of the developing neural crest","volume":"13","author":"van Noesel","year":"2012","journal-title":"Lancet Oncol"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002067","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T20:14:13Z","timestamp":1754338453000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,21]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000002067","relation":{},"ISSN":["1077-4114"],"issn-type":[{"type":"print","value":"1077-4114"}],"subject":[],"published":{"date-parts":[[2021,4,21]]},"assertion":[{"value":"2020-11-08","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-13","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}